Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 12:53 AM
NCT ID:
NCT02986867
Eligibility Criteria:
Inclusion Criteria:
* Histologic diagnosis of advanced/metastatic urothelial carcinoma, melanoma, or cervical carcinoma.
* Planned treated with SAbR.
* Age greater than or equal to 18 years.
* Lesion to receive SAbR safely accessible for core biopsy-mass \>1.5cm diameter and located in node, liver, or soft tissues.
* Hgb \>10g/dL before or after transfusion.
* Platelets \>50,000/L
* INR \<1.5
* If contrast enhanced CT needed to locate the lesion for core biopsy, then derived creatinine clearance \>30cc/min
* Ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria:
* Prior radiation therapy to target lesion.
* Target lesion not safely accessible for core biopsies.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02986867
Study Brief:
Protocol Section:
NCT02986867